Login
$GOVX
$0.20 -$0.00 (1.44%) Close

$GOVX 4 SEC Filings

Filed On Filing
22 Jun 2026 Form 4: Spencer John N Jr, Director

Granted 6,000 Stock Option

22 Jun 2026 Form 4: Morgan Jayne, Director

Granted 6,000 Stock Option

22 Jun 2026 Form 4: Mcnally Robert T, Director

Granted 6,000 Stock Option

22 Jun 2026 Form 4: Lemerond Nicole, Director

Granted 6,000 Stock Option

22 Jun 2026 Form 4: Kollintzas Dean G, Director

Granted 6,000 Stock Option

22 Jun 2026 Form 4: Chase Randal D, Director

Granted 6,000 Stock Option

22 Jun 2026 Form 4: Sharkey John W., VP, Business Development

Granted 17,600 Stock Option

22 Jun 2026 Form 4: Reynolds Mark, CFO

Granted 17,600 Stock Option

22 Jun 2026 Form 4: Newman Mark J, Chief Scientific Officer

Granted 17,600 Stock Option

22 Jun 2026 Form 4: McKee Kelly T. Jr., Chief Medical Officer

Granted 17,600 Stock Option

22 Jun 2026 Form 4: Dodd David A, Director

Granted 29,300 Stock Option

20 Oct 2025 Form 4: Spencer John N Jr, Director

Bought 10,000 shares ($5.5K)

08 Aug 2025 Form 4: McKee Kelly T. Jr., Chief Medical Officer

Bought 1,107 shares ($742)

06 Jun 2025 Form 4: Lemerond Nicole, Director

Granted 10,000 Stock Option

06 Jun 2025 Form 4: Chase Randal D, Director

Granted 10,000 Stock Option

06 Jun 2025 Form 4: Kollintzas Dean G, Director

Granted 10,000 Stock Option

06 Jun 2025 Form 4: Mcnally Robert T, Director

Granted 10,000 Stock Option

06 Jun 2025 Form 4: Morgan Jayne, Director

Granted 10,000 Stock Option

06 Jun 2025 Form 4: Spencer John N Jr, Director

Granted 10,000 Stock Option

06 Jun 2025 Form 4: Newman Mark J, Chief Scientific Officer

Granted 70,000 Stock Option

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support